{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:35:44Z","timestamp":1793363744412,"version":"4.5.0"},"reference-count":287,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jpba.2021.114479","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T02:14:53Z","timestamp":1637720093000},"page":"114479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future"],"prefix":"10.1016","volume":"209","author":[{"given":"M\u00fcnteha Nur Sonu\u00e7","family":"Karabo\u011fa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Kemal","family":"Sezgint\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib1","first-page":"115","article-title":"\u0130nflamasyon ve N\u00f6rodejeneratif Hastal\u0131klar","volume":"28","author":"KARA","year":"2008","journal-title":"Turk. Klin. J. Med. Sci."},{"issue":"7628","key":"10.1016\/j.jpba.2021.114479_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaging.2012.12.006","article-title":"Relationship goals of middle-aged, young-old, and old-old internet daters: an analysis of online personal ads","volume":"27","author":"Alterovitz","year":"2013","journal-title":"J. Aging Stud."},{"issue":"7","key":"10.1016\/j.jpba.2021.114479_bib4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1742-4658.2006.05181.x","article-title":"Protein\u2010misfolding diseases and chaperone\u2010based therapeutic approaches, The","volume":"273","author":"Chaudhuri","year":"2006","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00018-019-03298-9","article-title":"What is strain in neurodegenerative diseases?","volume":"77","author":"Tian","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jpba.2021.114479_bib6","doi-asserted-by":"crossref","unstructured":"A.S. Association, Alzheimer's disease facts and figures, Alzheimer's & Dementia 15(3) (2019) 321\u2013387.","DOI":"10.1016\/j.jalz.2019.01.010"},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1474-4422(17)30223-5","article-title":"Diagnostic biomarkers for Alzheimer\u2019s disease: a regulatory view","volume":"16","author":"Isaac","year":"2017","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib8","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.bios.2004.10.026","article-title":"Evanescent wave fluorescence biosensors","volume":"20","author":"Taitt","year":"2005","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jpba.2021.114479_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bios.2016.08.028","article-title":"Biosensors for breast cancer diagnosis: a review of bioreceptors, biotransducers and signal amplification strategies","volume":"88","author":"Mittal","year":"2017","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jpba.2021.114479_bib10","first-page":"271","article-title":"Diagnostic biosensors in medicine\u2013a review, biocatalysis and agricultural","volume":"17","author":"Metkar","year":"2019","journal-title":"Biotechnology"},{"key":"10.1016\/j.jpba.2021.114479_bib11","doi-asserted-by":"crossref","unstructured":"K.M. Bell, S.E. Kornguth, Biosensors for Neurological Disease, Handbook of Biosensors and Biochips (2007).","DOI":"10.1002\/9780470061565.hbb139"},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/bios10080101","article-title":"Electrochemical detection of neurotransmitters","volume":"10","author":"Banerjee","year":"2020","journal-title":"Biosensors"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/chemosensors6010001","article-title":"Recent advances in the detection of neurotransmitters","volume":"6","author":"Si","year":"2018","journal-title":"Chemosensors"},{"key":"10.1016\/j.jpba.2021.114479_bib14","doi-asserted-by":"crossref","DOI":"10.2174\/0929867327666201111141341","article-title":"Recent advancements in electrochemical biosensors for alzheimer\u2019s disease biomarkers detection","author":"Miku\u0142a","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.jpba.2021.114479_bib15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00702-009-0240-y","article-title":"Recent advances in our understanding of neurodegeneration","volume":"116","author":"Jellinger","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jpba.2021.114479_bib16","series-title":"Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders","author":"Dickson","year":"2011"},{"issue":"7","key":"10.1016\/j.jpba.2021.114479_bib17","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jpba.2021.114479_bib18","series-title":"Neurodegenerative Disease: Models, Mechanisms, and a New Hope","author":"Gitler","year":"2017"},{"key":"10.1016\/j.jpba.2021.114479_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pneurobio.2015.07.003","article-title":"Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies","volume":"155","author":"Bourdenx","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jpba.2021.114479_bib20","doi-asserted-by":"crossref","unstructured":"R. Pal, J.P. Larsen, S.G. Moller, The potential of proteomics in understanding neurodegeneration, International Review of Neurobiology, Elsevier 2015, 25\u201358.","DOI":"10.1016\/bs.irn.2015.05.002"},{"issue":"10","key":"10.1016\/j.jpba.2021.114479_bib21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs","volume":"10","author":"Forman","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpba.2021.114479_bib22","doi-asserted-by":"crossref","unstructured":"F. Orosz, A. Lehotzky, J. Ol\u00e1h, J. Ov\u00e1di, TPPP\/p25: A new unstructured protein hallmarking synucleinopathies, Protein folding and misfolding: neurodegenerative diseases\u00a0(2009) 225\u2013250.","DOI":"10.1007\/978-1-4020-9434-7_10"},{"key":"10.1016\/j.jpba.2021.114479_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ejmech.2016.07.054","article-title":"Protein aggregation and neurodegenerative diseases: From theory to therapy","volume":"124","author":"Kumar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2353\/ajpath.2010.080797","article-title":"Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy","volume":"176","author":"Nilsson","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"7143","key":"10.1016\/j.jpba.2021.114479_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature05695","article-title":"Atomic structures of amyloid cross-\u03b2 spines reveal varied steric zippers","volume":"447","author":"Sawaya","year":"2007","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib26","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1073\/pnas.0915166107","article-title":"Identifying the amylome, proteins capable of forming amyloid-like fibrils","volume":"107","author":"Goldschmidt","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"41","key":"10.1016\/j.jpba.2021.114479_bib28","doi-asserted-by":"crossref","first-page":"12722","DOI":"10.1523\/JNEUROSCI.3767-09.2009","article-title":"Four decades of neurodegenerative disease research: how far we have come!","volume":"29","author":"Young","year":"2009","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0197-4580(97)00047-X","article-title":"Prevalence, incidence and duration of Braak\u2019s stages in the general population: can we know?","volume":"18","author":"Duyckaerts","year":"1997","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early A\u03b2 accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-4-27","article-title":"Neurodegeneration in Alzheimer\u2019s disease: caspases and synaptic element interdependence","volume":"4","author":"Bredesen","year":"2009","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib33","first-page":"289","article-title":"Preclinical progression of neurodegenerative diseases","volume":"80","author":"Katsuno","year":"2018","journal-title":"Nagoya J. Med. Sci."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/cc.23067","article-title":"Early detection of neurodegenerative diseases: circulating brain-enriched microRNA","volume":"12","author":"Sheinerman","year":"2013","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/1567205013666151116141603","article-title":"Diagnosis of neurodegenerative diseases: the clinical approach","volume":"13","author":"G\u00f3mez-R\u00edo","year":"2016","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib36","first-page":"347","article-title":"Pathogenesis of Alzheimer\u2019s disease","volume":"2","author":"Swerdlow","year":"2007","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"07","key":"10.1016\/j.jpba.2021.114479_bib38","doi-asserted-by":"crossref","DOI":"10.1142\/S0129065716500258","article-title":"Ensembles of deep learning architectures for the early diagnosis of the Alzheimer\u2019s disease","volume":"26","author":"Ortiz","year":"2016","journal-title":"Int. J. Neural Syst."},{"key":"10.1016\/j.jpba.2021.114479_bib39","first-page":"123","article-title":"Alzheimer\u2019s disease\u2013why we need early diagnosis","volume":"9","author":"Rasmussen","year":"2019","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib40","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/brain\/awp105","article-title":"Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve","volume":"132","author":"Querbes","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40120-017-0072-x","article-title":"A review of biomarkers for neurodegenerative disease: will they swing us across the valley?","volume":"6","author":"Beach","year":"2017","journal-title":"Neurol. Ther."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Colburn","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","article-title":"Amyloid biomarkers in Alzheimer\u2019s disease","volume":"36","author":"Blennow","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2021.114479_bib44","first-page":"1","article-title":"Relevance of biomarkers across different neurodegenerative diseases","volume":"12","author":"Ehrenberg","year":"2020","journal-title":"Alzheimer\u2019s. Res. Ther."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12264-017-0174-6","article-title":"Can biomarkers help the early diagnosis of Parkinson\u2019s disease?","volume":"33","author":"Le","year":"2017","journal-title":"Neurosci. Bull."},{"issue":"1\u20132","key":"10.1016\/j.jpba.2021.114479_bib46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0304-3940(01)01754-2","article-title":"Amyloid \u03b2 protein 1\u201340 and 1\u201342 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease","volume":"304","author":"Mehta","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exger.2009.09.008","article-title":"Biomarkers for Alzheimer\u2019s disease and other forms of dementia: clinical needs, limitations and future aspects","volume":"45","author":"Cedazo-Minguez","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/YCO.0000000000000179","article-title":"Cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: current limitations and recent developments","volume":"28","author":"Zetterberg","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jpba.2021.114479_bib49","unstructured":"G. Emilien, C. Durlach, K.L. Minaker, B. Winblad, S. Gauthier, J.-M. Maloteaux, Alzheimer disease: neuropsychology and pharmacology, Birkh\u00e4user, 2012."},{"key":"10.1016\/j.jpba.2021.114479_bib50","first-page":"24","article-title":"Alzheimer\u2019s disease: a clinical and basic science review","volume":"4","author":"Korolev","year":"2014","journal-title":"Med. Stud. Res. J."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s41745-017-0051-3","article-title":"Alzheimer\u2019s dementia: an overview","volume":"97","author":"Nahar","year":"2017","journal-title":"J. Indian Inst. Sci."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib52","doi-asserted-by":"crossref","first-page":"nrd2176","DOI":"10.1038\/nrd2176","article-title":"Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics","volume":"6","author":"Shaw","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11\u201312","key":"10.1016\/j.jpba.2021.114479_bib53","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1111\/j.1582-4934.2009.00889.x","article-title":"Neuronal death in Alzheimer\u2019s disease and therapeutic opportunities","volume":"13","author":"Donev","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"R1","key":"10.1016\/j.jpba.2021.114479_bib54","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","article-title":"Molecular mechanisms of neurodegeneration in Alzheimer\u2019s disease","volume":"19","author":"Crews","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib55","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","article-title":"The role of inflammation in Alzheimer\u2019s disease","volume":"37","author":"Tuppo","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jpba.2021.114479_bib57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S75546","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"11","author":"Zhang","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib59","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","article-title":"Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer\u2019s disease in the presenilin 1 E280A kindred: a case-control study","volume":"11","author":"Reiman","year":"2012","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/alz.038255","article-title":"World Alzheimer Report 2019: Attitudes to dementia, a global survey: public health: Engaging people in ADRD research","volume":"16","author":"Lynch","year":"2020","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.jpba.2021.114479_bib62","doi-asserted-by":"crossref","unstructured":"2020 Alzheimer's disease facts and figures, Alzheimer's & Dementia 16(3) (2020) 391\u2013460.","DOI":"10.1002\/alz.12068"},{"issue":"11","key":"10.1016\/j.jpba.2021.114479_bib63","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archneur.1997.00550230066019","article-title":"Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons","volume":"54","author":"Evans","year":"1997","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.jpba.2021.114479_bib64","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/brain\/awm177","article-title":"FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease","volume":"130","author":"Foster","year":"2007","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib65","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","article-title":"Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors","volume":"13","author":"Goldman","year":"2011","journal-title":"Genet. Med."},{"issue":"9","key":"10.1016\/j.jpba.2021.114479_bib66","first-page":"1143","article-title":"Practice parameter: diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology","volume":"56","author":"Knopman","year":"2001"},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/brainsci10080479","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease\u2014the challenges of pathological mimics and concomitant pathology","volume":"10","author":"King","year":"2020","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer\u2019s disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib69","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tibtech.2017.11.004","article-title":"Point-of-care devices using disease biomarkers to diagnose neurodegenerative disorders","volume":"36","author":"Wei","year":"2018","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib71","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11940-017-0484-z","article-title":"Current role for biomarkers in clinical diagnosis of Alzheimer disease and frontotemporal dementia","volume":"19","author":"Sheikh-Bahaei","year":"2017","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib72","first-page":"109","article-title":"Consensus report of the Working Group on Biological markers of Alzheimer\u2019s disease.[Ronald and Nancy Reagan Institute of the Alzheimer\u2019s Association and National Institute on Aging Working Group on Biological Markers of Alzheimer\u2019s Disease]","volume":"19","author":"Growdon","year":"1998","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib73","first-page":"11","article-title":"Genetik K\u00f6keni ve Biyobelirte\u00e7leri","volume":"5","author":"HANA\u011eASI","year":"2012","journal-title":"Turk. Klin. J. Neurol. Spec. Top."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","article-title":"Identifying and validating biomarkers for Alzheimer\u2019s disease","volume":"29","author":"Humpel","year":"2011","journal-title":"Trends Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.jpba.2021.114479_bib75","first-page":"5","article-title":"The study of Alzheimer\u2019s disease biomarkers","volume":"2","author":"Kerman","year":"2006","journal-title":"NanoBiotechnology"},{"key":"10.1016\/j.jpba.2021.114479_bib76","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","article-title":"Biomarkers in Parkinson\u2019s disease: Advances and strategies","volume":"22","author":"Delenclos","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib77","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-170680","article-title":"Cerebrospinal fluid biomarkers for early and differential Alzheimer\u2019s disease diagnosis","volume":"62","author":"Bjerke","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/brainsci10040245","article-title":"Salivary biomarkers: future approaches for early diagnosis of neurodegenerative diseases","volume":"10","author":"Schepici","year":"2020","journal-title":"Brain Sci."},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib79","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers","volume":"16","author":"Frisoni","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib80","unstructured":"D. Galimberti, E. Scarpini, Biomarkers for early diagnosis of Alzheimer's disease, Nova Science, 2008."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-161127","article-title":"Biomarkers for early diagnosis of alzheimer\u2019s disease in the oldest old: yes or no?","volume":"58","author":"Paolacci","year":"2017","journal-title":"J. Alzheimer\u2019s. Dis."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib82","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jalz.2006.05.2347","article-title":"Biochemical biomarkers of late-life dementia","volume":"2","author":"Clark","year":"2006","journal-title":"Alzheimer\u2019s Dement."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wad.0000191420.61260.a8","article-title":"The role of biomarkers in clinical trials for Alzheimer disease","volume":"20","author":"Thal","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.jpba.2021.114479_bib84","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fneur.2017.00102","article-title":"Alzheimer\u2019s disease: biomarkers in the genome, blood, and cerebrospinal fluid","volume":"8","author":"Huynh","year":"2017","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/bmm.09.84","article-title":"Blood-based biomarkers of Alzheimer\u2019s disease: challenging but feasible","volume":"4","author":"Thambisetty","year":"2010","journal-title":"Biomark. Med."},{"issue":"2010 (","key":"10.1016\/j.jpba.2021.114479_bib86","article-title":"CSF biomarkers for Alzheimer\u2019s disease diagnosis","author":"Anoop","year":"2010","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.jpba.2021.114479_bib87","doi-asserted-by":"crossref","unstructured":"N. El Kadmiri, N. Said, I. Slassi, B. El Moutawakil, S. Nadifi, Biomarkers for Alzheimer disease: classical and novel candidates\u2019 review, Neuroscience, 2017.","DOI":"10.1016\/j.neuroscience.2017.07.017"},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib88","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00406-012-0362-3","article-title":"Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer\u2019s disease and other neurodegenerative dementias","volume":"262","author":"Genius","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpba.2021.114479_bib89","doi-asserted-by":"crossref","unstructured":"A.D. Henriques, A.L. Benedet, E.F. Camargos, P. Rosa-Neto, O.T. N\u00f3brega, Fluid and imaging biomarkers for Alzheimer's disease: where we stand and where to head to, Experimental gerontology (2018).","DOI":"10.1016\/j.exger.2018.01.002"},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer\u2019s disease","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0250-2","article-title":"Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib92","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(88)90462-X","article-title":"Immunochemical identification of the serine protease inhibitor \u03b11-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease","volume":"52","author":"Abraham","year":"1988","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.10414","article-title":"Plasma and cerebrospinal fluid \u03b11\u2013antichymotrypsin levels in Alzheimer\u2019s disease: Correlation with cognitive impairment","volume":"53","author":"DeKosky","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib94","article-title":"Alpha 1-antichymotrypsin, an inflammatory protein overexpressed in the brains of patients with Alzheimer\u2019s disease, induces Tau hyperphosphorylation through c-Jun N-terminal kinase activation","volume":"2013","author":"Tyagi","year":"2013","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib95","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00406-017-0815-9","article-title":"Plasma levels of soluble amyloid precursor protein \u03b2 in symptomatic Alzheimer\u2019s disease","volume":"268","author":"Alexopoulos","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn.2017.29","article-title":"Not just amyloid: physiological functions of the amyloid precursor protein family","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib98","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(99)00929-5","article-title":"Levels of \u03b1-and \u03b2-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer\u2019s disease patients","volume":"278","author":"Sennvik","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"2012 (","key":"10.1016\/j.jpba.2021.114479_bib99","article-title":"Biomarkers in Alzheimer\u2019s disease: a review","author":"Chintamaneni","year":"2012","journal-title":"ISRN Pharmacol."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib100","first-page":"1","article-title":"\u03b2-secretase1 biological markers for Alzheimer\u2019s disease: state-of-art of validation and qualification","volume":"12","author":"Hampel","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib101","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000489847","article-title":"Neurogranin and BACE1 in CSF as potential biomarkers differentiating depression with cognitive deficits from early Alzheimer\u2019s disease: a pilot study","volume":"8","author":"Schipke","year":"2018","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib102","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2009.04.1230","article-title":"Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old","volume":"5","author":"Kravitz","year":"2009","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.jpba.2021.114479_bib103","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.archger.2009.09.028","article-title":"Is there a relationship between high C-reactive protein (CRP) levels and dementia?","volume":"49","author":"Mancinella","year":"2009","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"7","key":"10.1016\/j.jpba.2021.114479_bib104","first-page":"KE01","article-title":"Exploring biomarkers for Alzheimer\u2019s disease","volume":"10","author":"Sharma","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.jpba.2021.114479_bib105","doi-asserted-by":"crossref","first-page":"13281","DOI":"10.1038\/srep13281","article-title":"Monomeric C-reactive protein-a key molecule driving development of Alzheimer\u2019s disease associated with brain ischaemia?","volume":"5","author":"Slevin","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1750-3639.2011.00539.x","article-title":"Amyloid plaques dissociate pentameric to monomeric C\u2010reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer\u2019s disease?","volume":"22","author":"Strang","year":"2012","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib107","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.05.028","article-title":"Association of plasma C-reactive protein levels with the diagnosis of Alzheimer\u2019s disease","volume":"333","author":"Yarchoan","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib108","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2217\/bmm.09.83","article-title":"Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease","volume":"4","author":"Fagan","year":"2010","journal-title":"Biomark. Med."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib109","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archneur.64.3.366","article-title":"Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment","volume":"64","author":"Simonsen","year":"2007","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib110","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/j.1471-4159.2008.05558.x","article-title":"Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer\u2019s disease","volume":"106","author":"Zhou","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpba.2021.114479_bib111","series-title":"C1q, a Small Molecule with High Impact on Brain Development: Putative Role for Aging Processes and the Occurrence of Alzheimer\u2019s Disease","author":"Rupprecht","year":"2021"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib112","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2010-1222","article-title":"Role of oxidative stress in the progression of Alzheimer\u2019s disease","volume":"19","author":"Sultana","year":"2010","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib113","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neurobiolaging.2014.12.010","article-title":"Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer\u2019s disease patients are unchanged","volume":"36","author":"Timmer","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.jpba.2021.114479_bib114","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archneur.56.10.1241","article-title":"Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?","volume":"56","author":"Tumani","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnagi.2019.00254","article-title":"Role of neurofilament light chain as a potential biomarker for alzheimer\u2019s disease: a correlative meta-analysis","volume":"11","author":"Jin","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib116","first-page":"1","article-title":"Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease","volume":"10","author":"Lewczuk","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.jpba.2021.114479_bib117","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fnins.2020.00579","article-title":"Neurofilament-light chain as biomarker of neurodegenerative and rare diseases with high translational value","volume":"14","author":"Loeffler","year":"2020","journal-title":"Front. Neurosci."},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib118","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1021\/acschemneuro.9b00095","article-title":"Potential value of plasma amyloid-\u03b2, total tau, and neurofilament light for identification of early Alzheimer\u2019s disease","volume":"10","author":"Shi","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib119","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.24052","article-title":"Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration","volume":"75","author":"Scherling","year":"2014","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib120","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","article-title":"Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression","volume":"19","author":"Tortelli","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib121","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.metabol.2014.10.034","article-title":"Biomarkers in the diagnosis and management of Alzheimer\u2019s disease","volume":"64","author":"Wurtman","year":"2015","journal-title":"Metab. Clin. Exp."},{"issue":"10","key":"10.1016\/j.jpba.2021.114479_bib122","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/00207454.2020.1713776","article-title":"3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases","volume":"130","author":"Bandookwala","year":"2020","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib123","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10715762.2010.520014","article-title":"Roles of 3-nitrotyrosine-and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer\u2019s disease","volume":"45","author":"Butterfield","year":"2011","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib124","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/bmm.09.89","article-title":"Biomarkers of oxidative damage and inflammation in Alzheimer\u2019s disease","volume":"4","author":"Galasko","year":"2010","journal-title":"Biomark. Med."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0891988706291088","article-title":"Biomarkers in the diagnosis of Alzheimer\u2019s disease: are we ready?","volume":"19","author":"Sunderland","year":"2006","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"10","key":"10.1016\/j.jpba.2021.114479_bib126","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.neurol.2013.07.012","article-title":"Biomarkers of Alzheimer\u2019s disease: the present and the future","volume":"169","author":"Lehmann","year":"2013","journal-title":"Rev. Neurol."},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib127","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.chemphyslip.2011.04.002","article-title":"Oxysterols as biomarkers in neurodegenerative diseases","volume":"164","author":"Leoni","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jpba.2021.114479_bib128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2015.04.014","article-title":"The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer\u2019s disease, mild cognitive impairment or Parkinson\u2019s disease","volume":"283","author":"Dursun","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresrev.2009.05.003","article-title":"Plasma biomarkers for mild cognitive impairment and Alzheimer\u2019s disease","volume":"61","author":"Song","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003289","article-title":"Age and the association between apolipoprotein E genotype and Alzheimer disease: a cerebrospinal fluid biomarker\u2013based case\u2013control study","volume":"17","author":"Saddiki","year":"2020","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-020-0801-2","article-title":"Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer\u2019s disease and mild cognitive impairment","volume":"10","author":"Liu","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib132","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/labmed\/lmaa062","article-title":"Neurogranin as a novel biomarker in Alzheimer\u2019s Disease","volume":"52","author":"Agnello","year":"2021","journal-title":"Lab. Med."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib133","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A review of fluid biomarkers for Alzheimer\u2019s disease: moving from CSF to blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol. Ther."},{"issue":"11","key":"10.1016\/j.jpba.2021.114479_bib134","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","article-title":"Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease","volume":"72","author":"Kester","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134658","article-title":"Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer\u2019s disease","volume":"715","author":"Wang","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib136","first-page":"906","article-title":"YKL-40 as a potential biomarker and a possible target in therapeutic strategies of Alzheimer\u2019s disease","volume":"15","author":"Groblewska","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"10","key":"10.1016\/j.jpba.2021.114479_bib137","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib138","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/acn3.266","article-title":"Cerebrospinal fluid neurogranin and YKL\u201040 as biomarkers of Alzheimer\u2019s disease","volume":"3","author":"Janelidze","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib139","first-page":"1","article-title":"Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer\u2019s disease in a memory clinic cohort","volume":"7","author":"Kester","year":"2015","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.jpba.2021.114479_bib140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuroscience.2017.07.017","article-title":"Biomarkers for Alzheimer disease: classical and novel candidates\u2019 review","volume":"370","author":"El Kadmiri","year":"2018","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib141","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3233\/JAD-150705","article-title":"Predictive value of cerebrospinal fluid visinin-like protein-1 levels for Alzheimer\u2019s disease early detection and differential diagnosis in patients with mild cognitive impairment","volume":"50","author":"Babi\u0107 Leko","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib142","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.22448","article-title":"Visinin\u2010like protein\u20101: diagnostic and prognostic biomarker in Alzheimer disease","volume":"70","author":"Tarawneh","year":"2011","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jpba.2021.114479_bib143","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib144","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neuint.2017.05.010","article-title":"Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer\u2019s disease","volume":"108","author":"Lista","year":"2017","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib146","unstructured":"C.H. Waters, Diagnosis and management of Parkinson's disease, Professional Communications, 2008."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib147","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson\u2019s disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br. Med. Bull."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib148","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpba.2021.114479_bib149","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"9","key":"10.1016\/j.jpba.2021.114479_bib150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.jpba.2021.114479_bib151","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","article-title":"Pathological roles of \u03b1-synuclein in neurological disorders","volume":"10","author":"Vekrellis","year":"2011","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib152","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/nm.4001","article-title":"Proteostasis and aging","volume":"21","author":"Kaushik","year":"2015","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib153","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12035-012-8341-2","article-title":"Alpha-synuclein and protein degradation systems: a reciprocal relationship","volume":"47","author":"Xilouri","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpba.2021.114479_bib154","first-page":"71","article-title":"Pathophysiology and clinical assessment of parkinsonian symptoms and signs","volume":"59","author":"Jankovic","year":"2003","journal-title":"Neurol. Dis. Ther."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib155","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"5930","key":"10.1016\/j.jpba.2021.114479_bib156","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/305137a0","article-title":"Dopamine visualized in the basal ganglia of living man","volume":"305","author":"Garnett","year":"1983","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib157","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000314495","article-title":"Significance of MRI in diagnosis and differential diagnosis of Parkinson\u2019s disease","volume":"7","author":"Mahlknecht","year":"2010","journal-title":"Neurodegener. Dis."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib158","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","article-title":"Neuroimaging in Parkinson disease: from research setting to clinical practice","volume":"10","author":"Politis","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"9942","key":"10.1016\/j.jpba.2021.114479_bib159","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(14)60041-6","article-title":"Imaging insights into basal ganglia function, Parkinson's disease, and dystonia","volume":"384","author":"Stoessl","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","article-title":"Cerebrospinal fluid biomarkers in Parkinson disease","volume":"9","author":"Parnetti","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib161","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and \u03b1-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jpba.2021.114479_bib162","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fnagi.2018.00438","article-title":"Increased DJ-1 and \u03b1-synuclein in plasma neural-derived exosomes as potential markers for Parkinson\u2019s disease","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpba.2021.114479_bib163","doi-asserted-by":"crossref","unstructured":"H. Ariga, S.M. Iguchi-Ariga, DJ-1\/PARK7 protein: Parkinson\u2019s disease, Cancer and Oxidative Stress-Induced Diseases, Springer2017.","DOI":"10.1007\/978-981-10-6583-5"},{"issue":"7","key":"10.1016\/j.jpba.2021.114479_bib164","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awr015","article-title":"Salivary \u03b1-synuclein and DJ-1: potential biomarkers for Parkinson\u2019s disease","volume":"134","author":"Devic","year":"2011","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jpba.2021.114479_bib165","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.parkreldis.2015.07.021","article-title":"Elevated salivary protein in Parkinson\u2019s disease and salivary DJ-1 as a potential marker of disease severity","volume":"21","author":"Masters","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.jpba.2021.114479_bib166","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S1353-8020(13)70025-7","article-title":"Blood-based biomarkers for Parkinson\u2019s disease","volume":"20","author":"Chahine","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib167","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.23872","article-title":"Plasma apolipoprotein A1 as a biomarker for Parkinson disease","volume":"74","author":"Qiang","year":"2013","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib168","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.26290","article-title":"Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson\u2019s disease patients","volume":"30","author":"Swanson","year":"2015","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib169","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.20663","article-title":"Serum uric acid levels and the risk of Parkinson disease","volume":"58","author":"de Lau","year":"2005","journal-title":"Ann. Neurol."},{"issue":"13","key":"10.1016\/j.jpba.2021.114479_bib170","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta\u2010analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib171","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s11064-018-2522-y","article-title":"Changes in the serum urate level can predict the development of Parkinsonism in the 6-hydroxydopamine animal model","volume":"43","author":"Sarukhani","year":"2018","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib172","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/mds.27328","article-title":"Evaluation of salivary heme oxygenase\u20101 as a potential biomarker of early Parkinson\u2019s disease","volume":"33","author":"Song","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpba.2021.114479_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.621508","article-title":"Increased plasma heme oxygenase-1 levels in patients with early-stage Parkinson\u2019s disease","volume":"13","author":"Sun","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpba.2021.114479_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134359","article-title":"Levels of cortisol and neurotrophic factor brain-derived in Parkinson\u2019s disease","volume":"708","author":"Costa","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-018-0112-1","article-title":"Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"7","author":"Hirsch","year":"2018","journal-title":"Transl. Neurodegener."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib176","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1177\/0300060517748843","article-title":"Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson\u2019s disease or essential tremor","volume":"46","author":"Huang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jpba.2021.114479_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135480","article-title":"Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson\u2019s disease patients","volume":"741","author":"Huang","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib178","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.5665\/sleep.5846","article-title":"Orexin-A is associated with increases in cerebrospinal fluid phosphorylated-tau in cognitively normal elderly subjects","volume":"39","author":"Osorio","year":"2016","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib179","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2012-111655","article-title":"Altered CSF orexin and \u03b1-synuclein levels in dementia patients","volume":"29","author":"Wennstr\u00f6m","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2009.11.065","volume":"469","author":"Isobe","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib181","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000154597.24838.6B","article-title":"Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease","volume":"64","author":"Sato","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib182","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/bab.1621","article-title":"Biosensors: classifications, medical applications, and future prospective","volume":"65","author":"Alhadrami","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/EBC20150001","article-title":"Introduction to biosensors","volume":"60","author":"Bhalla","year":"2016","journal-title":"Essays Biochem."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib184","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/etc.4290","article-title":"Critical review: grand challenges in assessing the adverse effects of contaminants of emerging concern on aquatic food webs","volume":"38","author":"Nilsen","year":"2019","journal-title":"Environ. Toxicol. Chem."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib185","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.3390\/s100504558","article-title":"Glucose biosensors: an overview of use in clinical practice","volume":"10","author":"Yoo","year":"2010","journal-title":"Sensors"},{"key":"10.1016\/j.jpba.2021.114479_bib186","series-title":"Microbial Biotechnology: Basic Research and Applications","first-page":"317","article-title":"Biological biosensors for monitoring and diagnosis","author":"Singh","year":"2020"},{"key":"10.1016\/j.jpba.2021.114479_bib187","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/9781681085852117050007","article-title":"Biosensors for detection of neurotransmitters and neurodegenerative related diseases","volume":"5","author":"Evtugyn","year":"2017","journal-title":"Front. Clin. Drug Res. CNS Neurol. Disord."},{"key":"10.1016\/j.jpba.2021.114479_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2017.12.015","article-title":"Biosensors for Alzheimer\u2019s disease biomarker detection: a review","author":"Shui","year":"2018","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib189","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00018-016-2345-4","article-title":"Aptamer and its applications in neurodegenerative diseases","volume":"74","author":"Qu","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib190","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1039\/C4CC07037B","article-title":"Label-free detection of Alzheimer\u2019s disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide","volume":"51","author":"Zhao","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jpba.2021.114479_bib191","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bios.2015.05.017","article-title":"Label-free detection of ApoE4-mediated \u03b2-amyloid aggregation on single nanoparticle uncovering Alzheimer\u2019s disease","volume":"72","author":"Kang","year":"2015","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jpba.2021.114479_bib192","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/srep01537","article-title":"Ubiquinone-quantum dot bioconjugates for in vitro and intracellular complex I sensing","volume":"3","author":"Ma","year":"2013","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib193","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymeth.2012.03.016","article-title":"Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of \u03b1-synuclein and other proteins in cerebrospinal fluid","volume":"56","author":"Kruse","year":"2012","journal-title":"Methods"},{"key":"10.1016\/j.jpba.2021.114479_bib194","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.trac.2016.02.012","article-title":"Recent advances in biosensors for neurodegenerative disease detection","volume":"79","author":"Ganesh","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120644","article-title":"Applications of biosensors in Alzheimer's disease diagnosis","volume":"210","author":"Brazaca","year":"2020","journal-title":"Talanta"},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-019-3903-x","article-title":"An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-\u03b2 (1\u201342) using a microporous gold nanostructure","volume":"186","author":"Negahdary","year":"2019","journal-title":"Microchim. Acta"},{"issue":"17","key":"10.1016\/j.jpba.2021.114479_bib197","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.3390\/s20174748","article-title":"Electrochemical biosensors based on nanomaterials for early detection of Alzheimer\u2019s disease","volume":"20","author":"Toyos-Rodr\u00edguez","year":"2020","journal-title":"Sensors"},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib198","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/celc.201800848","article-title":"Electrochemical impedance spectroscopy based biosensors: mechanistic principles, analytical examples and challenges towards commercialization for assays of protein cancer biomarkers","volume":"6","author":"Bertok","year":"2019","journal-title":"ChemElectroChem"},{"issue":"22","key":"10.1016\/j.jpba.2021.114479_bib199","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.3390\/s20226443","article-title":"Advances in electrochemical impedance spectroscopy detection of endocrine disruptors","volume":"20","author":"Zamfir","year":"2020","journal-title":"Sensors"},{"key":"10.1016\/j.jpba.2021.114479_bib200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jelechem.2017.03.026","article-title":"Cyclic voltammetry and voltabsorptometry studies of redox mechanism of lumazine","volume":"791","author":"He","year":"2017","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib201","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.snb.2017.12.088","article-title":"Mechanistic modeling of cyclic voltammetry: a helpful tool for understanding biosensor principles and supporting design optimization","volume":"259","author":"Semenova","year":"2018","journal-title":"Sens. Actuators B: Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib202","article-title":"A nano-composite based regenerative neuro biosensor sensitive to Parkinsonism-associated protein DJ-1\/Park7 in cerebrospinal fluid and saliva","volume":"138","author":"Karabo\u011fa","year":"2021","journal-title":"Bioelectrochemistry"},{"issue":"9","key":"10.1016\/j.jpba.2021.114479_bib203","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1039\/c3ay40155c","article-title":"Electrochemical sensing and biosensing based on square wave voltammetry","volume":"5","author":"Chen","year":"2013","journal-title":"Anal. Methods"},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib204","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ab.2010.09.027","article-title":"Voltammetric techniques for the assay of pharmaceuticals\u2014a review","volume":"408","author":"Gupta","year":"2011","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib205","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s10439-011-0457-4","article-title":"Nanomaterial-based biosensor as an emerging tool for biomedical applications","volume":"40","author":"Lee","year":"2012","journal-title":"Ann. Biomed. Eng."},{"issue":"23","key":"10.1016\/j.jpba.2021.114479_bib206","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1021\/la503533g","article-title":"Biosensor regeneration: a review of common techniques and outcomes","volume":"31","author":"Goode","year":"2014","journal-title":"Langmuir"},{"key":"10.1016\/j.jpba.2021.114479_bib207","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-food-030216-025713","article-title":"Stability and stabilization of enzyme biosensors: the key to successful application and commercialization","volume":"9","author":"Reyes-De-Corcuera","year":"2018","journal-title":"Annu. Rev. Food Sci. Technol."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib208","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nature Rev. Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib209","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnagi.2016.00262","article-title":"Tau structures","volume":"8","author":"Avila","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib210","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00259-015-3231-2","article-title":"Tau imaging in neurodegenerative diseases","volume":"43","author":"Dani","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib211","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib212","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"2\u20133","key":"10.1016\/j.jpba.2021.114479_bib213","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbadis.2004.06.017","article-title":"Tau phosphorylation: physiological and pathological consequences","volume":"1739","author":"Stoothoff","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib214","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4103\/1673-5374.274329","article-title":"Toxic tau: structural origins of tau aggregation in Alzheimer\u2019s disease","volume":"15","author":"Al Mamun","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib215","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jpba.2021.114479_bib216","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib217","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-017-0489-6","article-title":"Atypical, non-standard functions of the microtubule associated Tau protein","volume":"5","author":"Sotiropoulos","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib219","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-8-20","article-title":"Fluid biomarkers in Alzheimer\u2019s disease\u2013current concepts","volume":"8","author":"Ros\u00e9n","year":"2013","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib221","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer\u2019s disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp. Gerontol."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib222","article-title":"Body fluid biomarkers in Alzheimer\u2019s disease","volume":"3","author":"Lu","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib223","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12031-017-0983-0","article-title":"Tau diagnostics and clinical studies","volume":"63","author":"Gozes","year":"2017","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib224","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.talanta.2007.06.009","article-title":"Detection of Alzheimer's tau protein using localised surface plasmon resonance-based immunochip","volume":"74","author":"Kerman","year":"2008","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib225","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00216-019-02350-8","article-title":"A dip-and-read optical aptasensor for detection of tau protein","volume":"412","author":"Ziu","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib226","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bios.2016.08.078","article-title":"Toward sensitive immuno-based detection of tau protein by surface plasmon resonance coupled to carbon nanostructures as signal amplifiers","volume":"93","author":"Lisi","year":"2017","journal-title":"Biosens. Bioelectron."},{"issue":"2013 (","key":"10.1016\/j.jpba.2021.114479_bib227","article-title":"Carbon nanotubes: a review on structure and their interaction with proteins","author":"Saifuddin","year":"2012","journal-title":"J. Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib228","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bios.2016.10.077","article-title":"Detection of the tau protein in human serum by a sensitive four-electrode electrochemical biosensor","volume":"92","author":"Wang","year":"2017","journal-title":"Biosens. Bioelectron."},{"issue":"15","key":"10.1016\/j.jpba.2021.114479_bib229","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1039\/C8AN00527C","article-title":"A novel electrochemical aptamer\u2013antibody sandwich assay for the detection of tau-381 in human serum","volume":"143","author":"Shui","year":"2018","journal-title":"Analyst"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A new class of polymers: starburst-dendritic macromolecules","volume":"17","author":"Tomalia","year":"1985","journal-title":"Polym. J."},{"issue":"8","key":"10.1016\/j.jpba.2021.114479_bib231","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1359-6446(01)01757-3","article-title":"Poly (amidoamine)(PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications","volume":"6","author":"Esfand","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2021.114479_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112238","article-title":"An electrochemical immunosensor using gold nanoparticles-PAMAM-nanostructured screen-printed carbon electrodes for tau protein determination in plasma and brain tissues from Alzheimer patients","volume":"163","author":"Razzino","year":"2020","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jpba.2021.114479_bib233","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.trac.2013.09.015","article-title":"Dendrimer-encapsulated and cored metal nanoparticles for electrochemical nanobiosensing","volume":"53","author":"Hasanzadeh","year":"2014","journal-title":"TrAC Trends Anal. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib234","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/bios7030029","article-title":"In vitro quantified determination of \u03b2-amyloid 42 peptides, a biomarker of neuro-degenerative disorders, in PBS and human serum using a simple, cost-effective thin gold film biosensor","volume":"7","author":"Dai","year":"2017","journal-title":"Biosensors"},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-020-04273-z","article-title":"Signal multi-amplified electrochemical biosensor for voltammetric determination of tau-441 protein in biological samples using carbon nanomaterials and gold nanoparticles to hint dementia","volume":"187","author":"Li","year":"2020","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.jpba.2021.114479_bib236","article-title":"Analysis of Tau-441 protein in clinical samples using rGO\/AuNP nanocomposite-supported disposable impedimetric neuro-biosensing platform: towards Alzheimer\u2019s disease detection","volume":"219","author":"Karaboga","year":"2020","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib237","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/bios9030084","article-title":"Development of a label-free electrochemical aptasensor for the detection of Tau381 and its preliminary application in AD and non-AD patients\u2019 sera","volume":"9","author":"Tao","year":"2019","journal-title":"Biosensors"},{"issue":"15","key":"10.1016\/j.jpba.2021.114479_bib238","doi-asserted-by":"crossref","first-page":"7793","DOI":"10.1021\/acs.analchem.6b01825","article-title":"Femtomolar detection of tau proteins in undiluted plasma using surface plasmon resonance","volume":"88","author":"Kim","year":"2016","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib239","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/nbdi.1998.0193","article-title":"Possible causes of Alzheimer\u2019s disease: amyloid fragments, free radicals, and calcium homeostasis","volume":"5","author":"H\u00f6lscher","year":"1998","journal-title":"Neurobiol. Dis."},{"issue":"31","key":"10.1016\/j.jpba.2021.114479_bib240","doi-asserted-by":"crossref","first-page":"18295","DOI":"10.1074\/jbc.271.31.18295","article-title":"Amyloid \u03b2-protein and the genetics of Alzheimer\u2019s disease","volume":"271","author":"Selkoe","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.jpba.2021.114479_bib241","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/febs.14004","article-title":"The discovery of Alzheimer\u2010causing mutations in the APP gene and the formulation of the \u201camyloid cascade hypothesis\u201d","volume":"284","author":"Hardy","year":"2017","journal-title":"FEBS J."},{"issue":"5580","key":"10.1016\/j.jpba.2021.114479_bib242","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"science"},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib243","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-2011-111928","article-title":"Hormesis and amyloid-\u03b2 protein: physiology or pathology?","volume":"29","author":"Morley","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib244","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1046\/j.1460-9568.2000.01344.x","article-title":"APP is required during an early phase of memory formation","volume":"12","author":"Mileusnic","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib245","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2013.12.018","article-title":"The role of amyloid-beta in the regulation of memory","volume":"88","author":"Morley","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2021.114479_bib246","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fnagi.2016.00015","article-title":"Alzheimer\u2019s biomarkers are correlated with brain connectivity in older adults differentially during resting and task states","volume":"8","author":"Jiang","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jpba.2021.114479_bib247","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jpba.2021.114479_bib248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-020-04267-x","article-title":"A label-free biosensor based on graphene and reduced graphene oxide dual-layer for electrochemical determination of beta-amyloid biomarkers","volume":"187","author":"Sethi","year":"2020","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.jpba.2021.114479_bib249","article-title":"Sensitive electrochemical detection of amyloid beta peptide in human serum using an interdigitated chain-shaped electrode","volume":"144","author":"Le","year":"2019","journal-title":"Biosens. Bioelectron."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib250","first-page":"379","article-title":"Thiolated protein A-functionalized bimetallic surface plasmon resonance chip for enhanced determination of amyloid beta 42","volume":"30","author":"Kim","year":"2019","journal-title":"Appl. Chem. Eng."},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib251","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.3390\/s110404030","article-title":"Surface plasmon resonance based biosensors for exploring the influence of alkaloids on aggregation of amyloid-\u03b2 peptide","volume":"11","author":"Krazi\u0144ski","year":"2011","journal-title":"Sensors"},{"key":"10.1016\/j.jpba.2021.114479_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2020.127710","article-title":"Gold nanoparticles assisted sensitivity improvement of interdigitated microelectrodes biosensor for amyloid-\u03b2 detection in plasma sample","volume":"308","author":"Yoo","year":"2020","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib253","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2147\/IJN.S152163","article-title":"A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers","volume":"13","author":"Sun","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jpba.2021.114479_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiosc.2021.03.016","article-title":"Development of liquid crystal biosensor for the detection of amyloid beta-42 levels associated with Alzheimer\u2019s disease","author":"Kemiklioglu","year":"2021","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.jpba.2021.114479_bib255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.snb.2016.07.181","article-title":"Pereira, Alzheimer\u2019s disease: development of a sensitive label-free electrochemical immunosensor for detection of amyloid beta peptide","volume":"239","author":"Carneiro","year":"2017","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib256","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelechem.2020.114017","article-title":"A novel electrochemical biosensor with molecularly imprinted polymers and aptamer-based sandwich assay for determining amyloid-\u03b2 oligomer","volume":"862","author":"You","year":"2020","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib257","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2020.128146","article-title":"Surface plasmon resonance biosensor for the detection of tau-amyloid \u03b2 complex","volume":"316","author":"\u0160pringer","year":"2020","journal-title":"Sens. Actuators B Chem."},{"issue":"6","key":"10.1016\/j.jpba.2021.114479_bib258","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.nano.2018.05.013","article-title":"Rapid multiplexed detection of beta-amyloid and total-tau as biomarkers for Alzheimer\u2019s disease in cerebrospinal fluid","volume":"14","author":"Song","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jpba.2021.114479_bib259","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib260","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bpa.12370","article-title":"Alpha\u2010synuclein as a biomarker for Parkinson\u2019s disease","volume":"26","author":"Atik","year":"2016","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib261","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-synuclein in Parkinson\u2019s disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jpba.2021.114479_bib262","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.jpba.2021.114479_bib263","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/00207454.2014.961454","article-title":"Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis","volume":"125","author":"Gao","year":"2015","journal-title":"Int. J. Neurosci."},{"issue":"20","key":"10.1016\/j.jpba.2021.114479_bib264","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jpba.2021.114479_bib265","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fneur.2019.01388","article-title":"Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson\u2019s disease","volume":"10","author":"Chang","year":"2020","journal-title":"Front. Neurol."},{"issue":"28","key":"10.1016\/j.jpba.2021.114479_bib266","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011337","article-title":"Gastrointestinal nervous system \u03b1-synuclein as a potential biomarker of Parkinson disease","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.jpba.2021.114479_bib267","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/nan.12486","article-title":"Detection of alpha\u2010synuclein conformational variants from gastro\u2010intestinal biopsy tissue as a potential biomarker for Parkinson\u2019s disease","volume":"44","author":"Ruffmann","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"15","key":"10.1016\/j.jpba.2021.114479_bib268","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","article-title":"Skin nerve \u03b1-synuclein deposits: a biomarker for idiopathic Parkinson disease","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib269","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2020.3311","article-title":"Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease","volume":"78","author":"Wang","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jpba.2021.114479_bib270","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.snb.2017.08.051","article-title":"Detection and differentiation of \u03b1-Synuclein monomer and fibril by chitosan film coated nanogold array on optical sensor platform","volume":"255","author":"Khatri","year":"2018","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib271","doi-asserted-by":"crossref","DOI":"10.1039\/D1SM00298H","article-title":"Simple, rapid and sensitive detection of Parkinson's disease related alpha-synuclein using a DNA aptamer assisted liquid crystal biosensor","author":"Yang","year":"2021","journal-title":"Soft Matter"},{"key":"10.1016\/j.jpba.2021.114479_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2020.105195","article-title":"Ultrasensitive detection of alpha-synuclein oligomer using a PolyD-glucosamine\/gold nanoparticle\/carbon-based nanomaterials modified electrochemical immunosensor in human plasma","volume":"158","author":"Tao","year":"2020","journal-title":"Microchem. J."},{"issue":"17","key":"10.1016\/j.jpba.2021.114479_bib273","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1021\/ac4011205","article-title":"Real-time electrochemical monitoring of adenosine triphosphate in the picomolar to micromolar range using graphene-modified electrodes","volume":"85","author":"Sanghavi","year":"2013","journal-title":"Anal. Chem."},{"issue":"1\u20132","key":"10.1016\/j.jpba.2021.114479_bib274","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-014-1308-4","article-title":"Nanomaterial-based electrochemical sensing of neurological drugs and neurotransmitters","volume":"182","author":"Sanghavi","year":"2015","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.jpba.2021.114479_bib275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.snb.2017.01.171","article-title":"Aptasensors for the selective detection of alpha-synuclein oligomer by colorimetry, surface plasmon resonance and electrochemical impedance spectroscopy","volume":"245","author":"Sun","year":"2017","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib276","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6526850","article-title":"High-affinity detection of alpha-synuclein by aptamer-gold conjugates on an amine-modified dielectric surface","volume":"2019","author":"You","year":"2019","journal-title":"J. Anal. Methods Chem."},{"key":"10.1016\/j.jpba.2021.114479_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelechem.2020.113994","article-title":"A nanospherical conjugated microporous polymer-graphene nanosheets modified molecularly imprinted electrochemical sensor for high sensitivity detection of \u03b1-Synuclein","volume":"862","author":"Ma","year":"2020","journal-title":"J. Electroanal. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2021.114479_bib278","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/s20030617","article-title":"An electrochemical immunosensor based on a self-assembled monolayer modified electrode for label-free detection of \u03b1-synuclein","volume":"20","author":"Ge","year":"2020","journal-title":"Sensors"},{"issue":"9","key":"10.1016\/j.jpba.2021.114479_bib279","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-020-04507-0","article-title":"SPR immunosensor combined with Ti 4+@ TiP nanoparticles for the evaluation of phosphorylated alpha-synuclein level","volume":"187","author":"Yin","year":"2020","journal-title":"Microchim. Acta"},{"issue":"2","key":"10.1016\/j.jpba.2021.114479_bib280","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1039\/C8AN01279B","article-title":"Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system","volume":"144","author":"Karabo\u011fa","year":"2019","journal-title":"Analyst"},{"issue":"1\u20133","key":"10.1016\/j.jpba.2021.114479_bib281","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000283480","article-title":"Neuroinflammation\u2013an early event in both the history and pathogenesis of Alzheimer\u2019s disease","volume":"7","author":"Eikelenboom","year":"2010","journal-title":"Neurodegener."},{"issue":"6301","key":"10.1016\/j.jpba.2021.114479_bib282","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jpba.2021.114479_bib283","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/14789450.2017.1304217","article-title":"Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"14","author":"Baldacci","year":"2017","journal-title":"Expert Rev. Proteom."},{"issue":"12","key":"10.1016\/j.jpba.2021.114479_bib284","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00415-011-6087-9","article-title":"Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer\u2019s disease","volume":"258","author":"Choi","year":"2011","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jpba.2021.114479_bib285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-018-0127-7","article-title":"Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer\u2019s disease","volume":"7","author":"Zhang","year":"2018","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jpba.2021.114479_bib286","first-page":"1","article-title":"Chitinase-3-like protein 1 (YKL-40) as a new biomarker in inflammation, oncology, and neurology","volume":"1","author":"Korolenko","year":"2020","journal-title":"Korean J.f Clin. Med."},{"key":"10.1016\/j.jpba.2021.114479_bib287","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bioelechem.2014.07.006","article-title":"Electrochemical detection of the disease marker human chitinase-3-like protein 1 by matching antibody-modified gold electrodes as label-free immunosensors","volume":"101","author":"Chaocharoen","year":"2015","journal-title":"Bioelectrochemistry"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521005902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521005902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:15:38Z","timestamp":1760001338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521005902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":287,"alternative-id":["S0731708521005902"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114479","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114479"}}